Ontify
⌘
S
⌘
S
Share
Amgen
Applied Molecular Genetics
American multinational biopharmaceutical company.
Wikipedia | Amgen
Statements about
Amgen
Stock Exchange
Nasdaq
(1/2/1990 - )
Ticker Symbol
:
AMGN
Start Time
:
1/2/1990
Hong Kong Exchanges And Clearing Ltd
Ticker Symbol
:
4332
Instance Of
Business
Enterprise
Public Company
Biopharmaceutical Company
Organization
Headquarters Location
Thousand Oaks
Country
United States
Inception
1980
Official Website
http://www.amgen.com/
Industry
Pharmaceutical Industry
Location of Formation
Thousand Oaks
Logo Image
Image
Total Revenue
16 items
20,063,000,000 United States dollar
(2014)
Point in Time
:
2014
14,771,000,000 United States dollar
(2007)
Point in Time
:
2007
15,003,000,000 United States dollar
(2008)
Point in Time
:
2008
14,642,000,000 United States dollar
(2009)
Point in Time
:
2009
15,053,000,000 United States dollar
(2010)
Point in Time
:
2010
15,582,000,000 United States dollar
(2011)
Point in Time
:
2011
17,265,000,000 United States dollar
(2012)
Point in Time
:
2012
18,676,000,000 United States dollar
(2013)
Point in Time
:
2013
21,662,000,000 United States dollar
(2015)
Point in Time
:
2015
22,991,000,000 United States dollar
(2016)
Point in Time
:
2016
22,849,000,000 United States dollar
(2017)
Point in Time
:
2017
23,747,000,000 United States dollar
(2018)
Point in Time
:
2018
23,362,000,000 United States dollar
(2019)
Point in Time
:
2019
25,424,000,000 United States dollar
(2020)
Point in Time
:
2020
25,979,000,000 United States dollar
(2021)
Point in Time
:
2021
26,323,000,000 United States dollar
(2022)
Point in Time
:
2022
Net Profit
16 items
5,158,000,000 United States dollar
(2014)
Point in Time
:
2014
3,078,000,000 United States dollar
(2007)
Point in Time
:
2007
4,052,000,000 United States dollar
(2008)
Point in Time
:
2008
4,605,000,000 United States dollar
(2009)
Point in Time
:
2009
4,627,000,000 United States dollar
(2010)
Point in Time
:
2010
3,683,000,000 United States dollar
(2011)
Point in Time
:
2011
4,345,000,000 United States dollar
(2012)
Point in Time
:
2012
5,081,000,000 United States dollar
(2013)
Point in Time
:
2013
6,939,000,000 United States dollar
(2015)
Point in Time
:
2015
7,722,000,000 United States dollar
(2016)
Point in Time
:
2016
1,979,000,000 United States dollar
(2017)
Point in Time
:
2017
8,394,000,000 United States dollar
(2018)
Point in Time
:
2018
7,842,000,000 United States dollar
(2019)
Point in Time
:
2019
7,264,000,000 United States dollar
(2020)
Point in Time
:
2020
5,893,000,000 United States dollar
(2021)
Point in Time
:
2021
6,552,000,000 United States dollar
(2022)
Point in Time
:
2022
Total Assets
69,009,000,000 United States dollar
(2014)
Point in Time
:
2014
Part Of
S&P 500
Nasdaq-100
Dow Jones Global Titans 50
S&P 100
Described at URL
http://www.fundinguniverse.com/compa ...
Legal Form
Public Limited Company (Belgium)
Delaware Corporation
Coordinate Location
Loading map...
34.1741°N 118.8506°W
Wikidata
